Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL Petr KOLEK Vítězslav SALAJKA Vítěslav KOUBKOVÁ Leona DIMKA Sixtová PETRUŽELKA Luboš ROUBEC Jaromír VYZULA Rostislav PAVLÍK Tomáš

Year of publication 2009
Type Article in Periodical
Magazine / Source Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non small cell lung cancer; erlotinib; treatment of "poor prognosis" patients
Description "Poor prognosis" NSCLC patients were treated with erlotinib and their survival of evaluated. Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info